Business

March 31, 2014

Oxygen Bio gets confirmation of FDA lifting hold on drug

Oxygen Biotherapeutics shares rose 3 percent Monday after the Morrisville company confirmed that it had gotten written confirmation from regulators that they have lifted their clinical hold on its treatment for traumatic brain injuries.

Related content

Comments

Videos

Editor's Choice Videos